Q4 and Full Year 2022 Conference Call
IM Cannabis is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets.
The ecosystem created through IMC’s multi-country operations leverages the Company’s unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become a preeminent cultivator and a distributor of high-quality cannabis.
The IM Cannabis ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. where it cultivates, imports, and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres, and logistical hubs in Israel that enable the safe delivery and quality control of IM Cannabis products throughout the entire value chain.
In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH (“Adjupharm”), where it also distributes cannabis to medical patients. In Canada, the Company operates through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
Offering Document under the Listed Issuer Financing Exemption
January 27, 2023
US investors cannot view or rely on the offering document.Download
Receive updates straight into your inbox
IM Cannabis Corp.
Director Investor & Public Relations
Computershare Investor Services Inc.
510 Burrard Street
Vancouver, BC V6C 3B9
Continental Stock Transfer & Trust, Co.
1 State Street
New York, NY 10004-1561